No black box warning on record for Rukobia

As of the latest FDA labeling reviewed, Rukobia (FOSTEMSAVIR TROMETHAMINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Rukobia medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapies. ( 5.1 ) • QTc prolongation: Use RUKOBIA with caution in patients with a history of QTc prolongation or with relevant pre-existing cardiac disease or who are taking drugs with a known risk of Torsade de Pointes. ( 5.2 ) • Elevations in hepatic transaminases in

No black box warning on record for Rukobia

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapies. ( 5.1 ) • QTc prolongation: Use RUKOBIA with caution in patients with a history of QTc prolongation or with relevant pre-existing cardiac disease or who are taking drugs with a known risk of Torsade de Pointes. ( 5.2 ) • Elevations in hepatic transaminases in

Rukobia Black Box Warning

No black box warning on record for Rukobia

Other warnings & precautions

Rukobia Black Box Warning

No black box warning on record for Rukobia

Other warnings & precautions